ProStrakan have extended its existing European licensing agreement for Rapinyl with its Swedish partner Orexo to include North America.
Filed under: Uncategorized | Tagged: agonist, Fentanyl, Opioid, Orexo, ProStrakan, Rapinyl
Name (required)
E-mail (will not be published) (required)
Website
Notify me of follow-up comments via email.
Notify me of new posts via email.
